Table 1.

Demographics and comorbidities of patients with and without stroke

CharacteristicTotal (N = 137)No stroke (n = 119)Stroke (n = 18)P*
Age, median (IQR), y 48.8 (35.3, 60.3) 46.7 (34.9, 58.9) 57.2 (49.9, 67.3) .028 
Race, %     
 White 32.8 33.6 27.8 .685 
 African American 62.0 60.5 72.2  
 Other 5.0 5.8  
Female sex, % 67.9 65.5 83.3 .178 
Stroke during acute TTP episode, % 9.5 8.4 16.7 .379 
Total number of TTP episodes, median, IQR 1 (1, 2) 1 (1, 2) 2 (1, 2) .083 
Hypertension, % 45.3 41.2 72.2 .021 
Diabetes mellitus, % 22.6 20.2 38.9 .126 
Obesity (BMI >30), % 29.2 30.3 22.2 .347 
Dyslipidemia, % 17.5 15.1 33.3 .090 
Atrial fibrillation, % 5.8 5.9 5.6 .956 
SLE, % 8.0 6.7 16.7 .160 
Other autoimmune disorder, % 8.0 6.7 16.7 .160 
Chronic kidney disease, % 16.8 16.0 22.2 .737 
Current smoking, % 14.6 12.7 22.2 .220 
CharacteristicTotal (N = 137)No stroke (n = 119)Stroke (n = 18)P*
Age, median (IQR), y 48.8 (35.3, 60.3) 46.7 (34.9, 58.9) 57.2 (49.9, 67.3) .028 
Race, %     
 White 32.8 33.6 27.8 .685 
 African American 62.0 60.5 72.2  
 Other 5.0 5.8  
Female sex, % 67.9 65.5 83.3 .178 
Stroke during acute TTP episode, % 9.5 8.4 16.7 .379 
Total number of TTP episodes, median, IQR 1 (1, 2) 1 (1, 2) 2 (1, 2) .083 
Hypertension, % 45.3 41.2 72.2 .021 
Diabetes mellitus, % 22.6 20.2 38.9 .126 
Obesity (BMI >30), % 29.2 30.3 22.2 .347 
Dyslipidemia, % 17.5 15.1 33.3 .090 
Atrial fibrillation, % 5.8 5.9 5.6 .956 
SLE, % 8.0 6.7 16.7 .160 
Other autoimmune disorder, % 8.0 6.7 16.7 .160 
Chronic kidney disease, % 16.8 16.0 22.2 .737 
Current smoking, % 14.6 12.7 22.2 .220 

BMI, body mass index.

*

Fisher's exact test (categorical variables), Mann-Whitney U test (continuous variables).

or Create an Account

Close Modal
Close Modal